Lu Tan
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Medicinal Plants and Bioactive Compounds 3
- Natural product bioactivities and synthesis 2
- Bioactive natural compounds 2
-
- Fungal Biology and Applications 4
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- Zhixing Cao (10 shared papers)Yuzhi Li (7 shared papers)Chuanjie Guo (7 shared papers)Xiaominting Song (7 shared papers)Yali Ren (4 shared papers)Miao Wang (3 shared papers)Cheng Peng (4 shared papers)Junlin He (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Molecules (2 papers)Pharmacological Research (1 paper)The FASEB Journal (1 paper)Natural Product Communications (1 paper)
- Partner nations
- ChinaUnited KingdomSwitzerland
In The Last Decade
Lu Tan
14 papers receiving 944 citations
Lu Tan's Hit Papers
Peers
Comparison fields: 5 of 96
- Toxicology 128
- Biochemistry 81
- Complementary and alternative medicine 74
- Pharmacology 135
- Pharmacology 65
Countries citing papers authored by Lu Tan
This map shows the geographic impact of Lu Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Tan more than expected).
Fields of papers citing papers by Lu Tan
This network shows the impact of papers produced by Lu Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Tan. The network helps show where Lu Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Myricetin: A review of the most recent research Hit paper breakdown → | 2020 | 285 |
| 2 | Pharmacological properties and derivatives of shikonin—A review in recent years Hit paper breakdown → | 2019 | 284 |
| 3 | 2020 | 103 | |
| 4 | 2020 | 76 | |
| 5 | 2020 | 55 | |
| 6 | 2019 | 46 | |
| 7 | 2020 | 40 | |
| 8 | 2019 | 22 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2018 | 5 | |
| 15 | Study on anti-depressant effect of water extract from Zhiqi medicinal fungal substance. | 2012 | 0 |
About Lu Tan
Lu Tan is a scholar working on Molecular Biology, Pharmacology, Plant Science, Complementary and alternative medicine and Organic Chemistry, having authored 15 papers that have together received 961 indexed citations. Recurring topics across this work include Fungal Biology and Applications (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Medicinal Plants and Bioactive Compounds (3 papers), Phytochemistry and Biological Activities (2 papers), Natural product bioactivities and synthesis (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Bioactive natural compounds (2 papers) and Sesquiterpenes and Asteraceae Studies (1 paper). The work is most often cited by research in Toxicology (128 citations), Biochemistry (81 citations), Complementary and alternative medicine (74 citations), Pharmacology (135 citations) and Pharmacology (65 citations). Lu Tan has collaborated with scholars based in China, United Kingdom and Switzerland. Frequent co-authors include Zhixing Cao, Yuzhi Li, Chuanjie Guo, Xiaominting Song, Yali Ren, Miao Wang, Cheng Peng, Junlin He, Peidu Jiang and Miao Wang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Molecules, Pharmacological Research, The FASEB Journal and Natural Product Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.